Skip to content
2000
Volume 10, Issue 4
  • ISSN: 1389-2010
  • E-ISSN: 1873-4316

Abstract

Hydroxyapatite (HA) has proven in recent years to be one of the most versatile and powerful methods for removing aggregates from antibody preparations. It is effective with IgA, IgG and IgM, and it reduces aggregate levels from above 60% to less than 0.1%. Three basic elution strategies have evolved, one that removes aggregates from a modest proportion of clones, another from the majority, and one that appears to be universally effective. Each has distinct development and process ramifications. This review defines what HA is, how it interacts with various classes of biomolecules, how those interactions are controlled by different elution strategies, and how to determine which approach may be most effective for a particular antibody. Consideration is also given to HA's specific strengths and limitations from an industrial perspective.

Loading

Article metrics loading...

/content/journals/cpb/10.2174/138920109788488833
2009-06-01
2025-04-13
Loading full text...

Full text loading...

/content/journals/cpb/10.2174/138920109788488833
Loading

  • Article Type:
    Research Article
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test